I also want to note and acknowledge the previous select committee, the select committee process in 2017 where this bill has spent quite some time. On the surface, I think, as Shane Reti acknowledged at the very beginning of this debate, the majority of submitters at that select committee process in 2017 were opposed to the bill. But it's really important, I think, to sort of take a step back and look at what that means. And, you know, first and foremost, the majority of organisations and individuals in the fields of either medicine or dentistry did support the bill. And although the submissions were somewhat thought-provoking, a substantial number dealt with the relative merits or otherwise of water fluoridation, which, as we've heard here tonight and which many of us will know from previous experience, is a really complex issue. And it falls outside the scope of this bill, which, in its most recent iteration with the Supplementary Order Paper (SOP) incorporated in it, seeks to enable the Director-General of Health to make decisions about that fluoridation.